{"id":"https://openalex.org/W2013973828","doi":"https://doi.org/10.1038/bcj.2014.66","title":"Rapid clinical improvement of peripheral artery occlusive disease symptoms after nilotinib discontinuation despite persisting vascular occlusion","display_name":"Rapid clinical improvement of peripheral artery occlusive disease symptoms after nilotinib discontinuation despite persisting vascular occlusion","publication_year":2014,"publication_date":"2014-09-19","ids":{"openalex":"https://openalex.org/W2013973828","doi":"https://doi.org/10.1038/bcj.2014.66","mag":"2013973828","pmid":"https://pubmed.ncbi.nlm.nih.gov/25238138","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4183775"},"language":"en","primary_location":{"id":"doi:10.1038/bcj.2014.66","doi":"https://doi.org/10.1038/bcj.2014.66","is_oa":true,"landing_page_url":"https://doi.org/10.1038/bcj.2014.66","pdf_url":"https://www.nature.com/articles/bcj201466.pdf","source":{"id":"https://openalex.org/S2496263508","display_name":"Blood Cancer Journal","issn_l":"2044-5385","issn":["2044-5385"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Cancer Journal","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.nature.com/articles/bcj201466.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044859671","display_name":"Aur\u00e9lien Maurizot","orcid":"https://orcid.org/0000-0002-8742-1195","observed_orcids":["https://orcid.org/0000-0002-8742-1195"]},"institutions":[{"id":"https://openalex.org/I4210159263","display_name":"Centre Hospitalier de Versailles","ror":"https://ror.org/053evvt91","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210159263"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"A Maurizot","raw_affiliation_strings":["Department of Cardiology, Centre Hospitalier de Versailles, Le Chesnay, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology, Centre Hospitalier de Versailles, Le Chesnay, France","institution_ids":["https://openalex.org/I4210159263"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111744516","display_name":"J-P Beressi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159263","display_name":"Centre Hospitalier de Versailles","ror":"https://ror.org/053evvt91","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210159263"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J-P Beressi","raw_affiliation_strings":["Department of Diabetology and Endocrinology, Centre Hospitalier de Versailles, Le Chesnay, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Diabetology and Endocrinology, Centre Hospitalier de Versailles, Le Chesnay, France","institution_ids":["https://openalex.org/I4210159263"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085749569","display_name":"Benjamin Man\u00e9glier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159263","display_name":"Centre Hospitalier de Versailles","ror":"https://ror.org/053evvt91","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210159263"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"B Man\u00e9glier","raw_affiliation_strings":["Department of Biologie M\u00e9dicale, Pharmacoogy Unit, Centre Hospitalier de Versailles, Le Chesnay, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biologie M\u00e9dicale, Pharmacoogy Unit, Centre Hospitalier de Versailles, Le Chesnay, France","institution_ids":["https://openalex.org/I4210159263"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038855695","display_name":"N H de la Marre","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N H de la Marre","raw_affiliation_strings":["Vascular Medicine Private Practice, Guyancourt, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vascular Medicine Private Practice, Guyancourt, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058750345","display_name":"Marc Spentchian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159263","display_name":"Centre Hospitalier de Versailles","ror":"https://ror.org/053evvt91","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210159263"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M Spentchian","raw_affiliation_strings":["Department of Biologie M\u00e9dicale, Pharmacoogy Unit, Centre Hospitalier de Versailles, Le Chesnay, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biologie M\u00e9dicale, Pharmacoogy Unit, Centre Hospitalier de Versailles, Le Chesnay, France","institution_ids":["https://openalex.org/I4210159263"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112829620","display_name":"Patrick Soury","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Soury","raw_affiliation_strings":["Department of Vascular Surgery, H\u00f4pital Priv\u00e9 de l'Ouest Parisien, Trappes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Vascular Surgery, H\u00f4pital Priv\u00e9 de l'Ouest Parisien, Trappes, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089332438","display_name":"P Solvet-Sebire","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Solvet-Sebire","raw_affiliation_strings":["Department of Medical Imaging, H\u00f4pital Priv\u00e9 de l'Ouest Parisien, Trappes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Imaging, H\u00f4pital Priv\u00e9 de l'Ouest Parisien, Trappes, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016654782","display_name":"Carole Collet-Gaudillat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159263","display_name":"Centre Hospitalier de Versailles","ror":"https://ror.org/053evvt91","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210159263"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C Collet-Gaudillat","raw_affiliation_strings":["Department of Diabetology and Endocrinology, Centre Hospitalier de Versailles, Le Chesnay, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Diabetology and Endocrinology, Centre Hospitalier de Versailles, Le Chesnay, France","institution_ids":["https://openalex.org/I4210159263"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110913247","display_name":"J.-M. Baud","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159263","display_name":"Centre Hospitalier de Versailles","ror":"https://ror.org/053evvt91","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210159263"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J-M Baud","raw_affiliation_strings":["Department of Cardiology, Centre Hospitalier de Versailles, Le Chesnay, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology, Centre Hospitalier de Versailles, Le Chesnay, France","institution_ids":["https://openalex.org/I4210159263"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061777326","display_name":"B. Livarek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159263","display_name":"Centre Hospitalier de Versailles","ror":"https://ror.org/053evvt91","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210159263"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"B Livarek","raw_affiliation_strings":["Department of Cardiology, Centre Hospitalier de Versailles, Le Chesnay, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology, Centre Hospitalier de Versailles, Le Chesnay, France","institution_ids":["https://openalex.org/I4210159263"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079181777","display_name":"Fran\u00e7ois Guilhot","orcid":"https://orcid.org/0000-0001-7222-487X","observed_orcids":["https://orcid.org/0000-0001-7222-487X"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210111187","display_name":"Centre Hospitalier Universitaire de Poitiers","ror":"https://ror.org/029s6hd13","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210111187"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"F Guilhot","raw_affiliation_strings":["Inserm CIC 802 Unit, CHU de Poitiers, Poitiers, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inserm CIC 802 Unit, CHU de Poitiers, Poitiers, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210111187"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052564121","display_name":"Philippe H. Rousselot","orcid":"https://orcid.org/0000-0003-3238-4494","observed_orcids":["https://orcid.org/0000-0003-3238-4494"]},"institutions":[{"id":"https://openalex.org/I195731000","display_name":"Universit\u00e9 de Versailles Saint-Quentin-en-Yvelines","ror":"https://ror.org/03mkjjy25","country_code":"FR","type":"education","lineage":["https://openalex.org/I195731000","https://openalex.org/I277688954"]},{"id":"https://openalex.org/I4210159263","display_name":"Centre Hospitalier de Versailles","ror":"https://ror.org/053evvt91","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210159263"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"P Rousselot","raw_affiliation_strings":["1] Department of Hematology and Oncology, Centre Hospitalier de Versailles, Le Chesnay, France [2] Universit\u00e9 Versailles Saint-Quentin-en-Yvelines, Versailles, France","Department of Hematology and Oncology, Centre Hospitalier de Versailles, Le Chesnay, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1] Department of Hematology and Oncology, Centre Hospitalier de Versailles, Le Chesnay, France [2] Universit\u00e9 Versailles Saint-Quentin-en-Yvelines, Versailles, France","institution_ids":["https://openalex.org/I195731000","https://openalex.org/I4210159263"]},{"raw_affiliation_string":"Department of Hematology and Oncology, Centre Hospitalier de Versailles, Le Chesnay, France","institution_ids":["https://openalex.org/I4210159263"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5052564121"],"corresponding_institution_ids":["https://openalex.org/I195731000","https://openalex.org/I4210159263"],"apc_list":{"value":5290,"currency":"USD","value_usd":5290},"apc_paid":{"value":5290,"currency":"USD","value_usd":5290},"fwci":0.6364,"has_fulltext":true,"cited_by_count":16,"citation_normalized_percentile":{"value":0.71469174,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"4","issue":"9","first_page":"e247","last_page":"e247"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.8701000213623047,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.8701000213623047,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10926","display_name":"Peripheral Artery Disease Management","score":0.08550000190734863,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0066999997943639755,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/peripheral-arterial-disease","display_name":"peripheral arterial disease","score":0.9879999756813049},{"id":"https://openalex.org/keywords/nilotinib","display_name":"nilotinib","score":0.9950000047683716},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9829999804496765},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.824999988079071},{"id":"https://openalex.org/keywords/medication-discontinuation","display_name":"drug discontinuation","score":0.7369999885559082},{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":0.7360000014305115},{"id":"https://openalex.org/keywords/bcr-abl-tyrosine-kinase-inhibitors","display_name":"BCR-ABL tyrosine kinase inhibitors","score":0.7400000095367432}],"concepts":[{"id":"https://openalex.org/C2777413986","wikidata":"https://www.wikidata.org/wiki/Q412327","display_name":"Nilotinib","level":4,"score":0.9865226745605469},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9112486243247986},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6672395467758179},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.5885919332504272},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.5410955548286438},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5050883889198303},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.44358018040657043},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4379293918609619},{"id":"https://openalex.org/C2780381907","wikidata":"https://www.wikidata.org/wiki/Q198728","display_name":"Ponatinib","level":5,"score":0.42829179763793945},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.42528867721557617},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.1398124098777771},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D005128","descriptor_name":"Eye Diseases","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D005128","descriptor_name":"Eye Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011859","descriptor_name":"Radiography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014973","descriptor_name":"Xanthomatosis","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D014973","descriptor_name":"Xanthomatosis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D058729","descriptor_name":"Peripheral Arterial Disease","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D058729","descriptor_name":"Peripheral Arterial Disease","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1038/bcj.2014.66","doi":"https://doi.org/10.1038/bcj.2014.66","is_oa":true,"landing_page_url":"https://doi.org/10.1038/bcj.2014.66","pdf_url":"https://www.nature.com/articles/bcj201466.pdf","source":{"id":"https://openalex.org/S2496263508","display_name":"Blood Cancer Journal","issn_l":"2044-5385","issn":["2044-5385"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Cancer Journal","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3157249","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4183775","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4183775","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4183775","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Cancer J","raw_type":"Text"},{"id":"pmid:25238138","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25238138","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood cancer journal","raw_type":"Case Reports"}],"best_oa_location":{"id":"doi:10.1038/bcj.2014.66","doi":"https://doi.org/10.1038/bcj.2014.66","is_oa":true,"landing_page_url":"https://doi.org/10.1038/bcj.2014.66","pdf_url":"https://www.nature.com/articles/bcj201466.pdf","source":{"id":"https://openalex.org/S2496263508","display_name":"Blood Cancer Journal","issn_l":"2044-5385","issn":["2044-5385"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Cancer Journal","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2013973828.pdf","grobid_xml":"https://content.openalex.org/works/W2013973828.grobid-xml"},"referenced_works_count":10,"referenced_works":["https://openalex.org/W1977996924","https://openalex.org/W2051566553","https://openalex.org/W2061440903","https://openalex.org/W2068248632","https://openalex.org/W2072834954","https://openalex.org/W2093608520","https://openalex.org/W2096227601","https://openalex.org/W2122549521","https://openalex.org/W2124196948","https://openalex.org/W2140259730"],"related_works":["https://openalex.org/W2051566553","https://openalex.org/W184204028","https://openalex.org/W2068248632","https://openalex.org/W2093608520","https://openalex.org/W2574990113","https://openalex.org/W2944138627","https://openalex.org/W1977996924","https://openalex.org/W2979821888","https://openalex.org/W2140259730","https://openalex.org/W2105348192"],"abstract_inverted_index":{"Peripheral":[0],"artery":[1],"occlusive":[2],"disease":[3],"(PAOD)":[4],"is":[5],"an":[6],"emerging":[7],"adverse":[8],"event":[9],"in":[10,48,76,84,104,124,157],"chronic":[11],"myelogenous":[12],"leukemia":[13],"(CML)":[14],"patients":[15,32,79,102,133,137,155],"treated":[16,33,156],"with":[17,34,66],"nilotinib.":[18],"1":[19],",":[20,22,24],"2":[21],"3":[23],"4":[25],"The":[26],"largest":[27],"published":[28,75],"cohort":[29],"of":[30,81,122,139],"CML":[31],"nilotinib":[35,57,86],"comes":[36],"from":[37,115],"the":[38,71,85,105,116,125,153,158],"phase":[39],"III":[40],"ENESTnd":[41],"trial":[42],"(Evaluating":[43],"Nilotinib":[44],"Efficacy":[45],"and":[46],"Safety":[47],"Clinical":[49],"Trials":[50],"-":[51],"newly":[52],"diagnosed":[53],"patients),":[54],"which":[55],"compared":[56,148],"(300":[58],"or":[59],"400":[60],"mg":[61],"BID)":[62],"to":[63,149],"standard":[64],"therapy":[65],"imatinib":[67,159],"(400":[68],"mg).":[69],"From":[70],"3-year":[72,117],"follow-up":[73],"analysis":[74,107,118],"2012,":[77],"8":[78],"out":[80,138],"556":[82,140],"(1.4%)":[83],"arm":[87],"were":[88,113],"identified":[89],"as":[90,108,119,145],"having":[91,109,146],"PAOD.":[92],"5":[93],"This":[94],"figure":[95],"does":[96],"not":[97],"take":[98],"into":[99],"account":[100],"three":[101,132],"reported":[103],"2-year":[106],"PAOD,":[110],"but":[111],"who":[112],"removed":[114],"a":[120],"result":[121],"changes":[123],"AE":[126],"search":[127],"algorithm.":[128],"6":[129],"When":[130],"these":[131],"are":[134],"included,":[135],"11":[136],"(2.0%)":[141],"can":[142],"be":[143],"considered":[144],"PAOD":[147],"no":[150],"cases":[151],"among":[152],"280":[154],"arm.":[160]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}